Fabrinet ($FN) reported earnings on August 17, 2026. The headline number: quarterly revenue grew 39.3% year over year, a sharp acceleration that puts $FN among the faster-growing names in the technology sector right now.
The stock was priced at $570.91 as of August 14, 2026, giving it a market cap of $18.88B. The trailing P/E stands at 49.0, but the forward P/E drops to 12.8 — a significant gap that reflects the market pricing in a meaningful earnings ramp ahead.
We do not have verified EPS growth figures for this quarter, so we are not publishing a growth percentage. For the latest per-share figures, visit the live $FN page on acceinvestments.com. We also do not have guidance commentary from management at this time.
Get the ACCE weekly digest
Index returns, picks recap, score movers - every Sunday. No fluff.
What it means
The ACCE score for $FN is 69 out of 100. Breaking that down:
Growth: 100/100 — the 39.3% revenue growth feeds directly into this perfect score.
Momentum: 84/100 — the stock has returned 77.3% over the past year, well ahead of most peers.
Quality: 65/100 — ROE of 20.0% and a net margin of 9.9% are solid for a contract manufacturer. Earnings quality is flagged as strong.
Value: 28/100 — this is the weak spot. At the current price, our 6-model fair value estimate comes in at $142.04, which implies the stock is trading at a substantial premium to that composite estimate. The analyst consensus target sits at $732.44, pointing in the opposite direction. These two figures reflect genuinely different views on what $FN's growth trajectory is worth.
The FCF yield of 1.1% is thin, which is consistent with a stock the market is pricing for continued high growth rather than current cash returns. $FN pays no dividend.
The wide spread between the 6-model fair value and the analyst target is worth noting. Investors who weight quantitative valuation models heavily will see a very different picture than those anchoring to sell-side price targets. Neither view is automatically correct — the 39.3% revenue growth is real, and the question is how long it continues.
For live price, updated score, and full earnings data, see acceinvestments.com/stocks/FN.
See the full picture, free
ACCE scores thousands of stocks across six valuation models, with fair value, conviction and the full thesis on every name. Start free, no card required.